Nova Patents
IL240597B

Ligand binding molecules and uses thereof

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

49 members in 26 offices

This recordMember, by publication datePriority claim16 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
201361765841United States of AmericaP
201361782376United States of AmericaP
2014000114AustraliaW

Members49

Family members, oldest first
DocumentOfficeKind
CA2901226A1CanadaA1
WO2014124487A1World Intellectual Property Organization (WIPO)A1
AU2014218318A1AustraliaA1
SG11201505940WASingaporeA
IL240597A0IsraelA0
IL240597D0IsraelD0
PH12015501785A1PhilippinesA1
EP2956476A1European Patent Office (EPO)A1
US2016002612A1United States of AmericaA1
MX2015010499AMexicoA
JP2016508372AJapanA
EP2956476A4European Patent Office (EPO)A4
ZA201506186BSouth AfricaB
RU2015137688ARussian FederationA
BR112015019721A2BrazilA2
US9745558B2United States of AmericaB2
US2017349886A1United States of AmericaA1
AU2014218318B2AustraliaB2
JP6408492B2JapanB2
JP2019023198AJapanA
MY170528AMalaysiaA
RU2699007C2Russian FederationC2
MX368730BMexicoB
US10494617B2United States of AmericaB2
NZ710658ANew ZealandA
EP2956476B1European Patent Office (EPO)B1
DK2956476T3DenmarkT3
PT2956476TPortugalT
LT2956476TLithuaniaT
SMT202000088T1San MarinoT1
SI2956476T1SloveniaT1
RS60026B1SerbiaB1
US2020165584A1United States of AmericaA1
IL240597AIsraelA
IL240597BThis recordIsraelB
HRP20200202T1CroatiaT1
ES2771478T3SpainT3
EP3693381A1European Patent Office (EPO)A1
HUE048687T2HungaryT2
PL2956476T3PolandT3
PL2956476T4PolandT4
CA2901226CCanadaC
CY1122678T1CyprusT1
MY199344AMalaysiaA
US11866739B2United States of AmericaB2
PH12015501785B1PhilippinesB1
US2024301370A1United States of AmericaA1
EP3693381B1European Patent Office (EPO)B1
EP3693381C0European Patent Office (EPO)C0